Preparation of substituted diaminopyrazine dicarboxylic acids

US12319660B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12319660-B2
Application numberUS-202217697275-A
CountryUS
Kind codeB2
Filing dateMar 17, 2022
Priority dateMar 31, 2021
Publication dateJun 3, 2025
Grant dateJun 3, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides improved methods for preparing a compound comprising Formula (I).

First claim

Opening claim text (preview).

What is claimed is: 1. A method for preparing a compound of Formula (I): the method comprising contacting 3,6-diamino-2,5-pyrazinedicarboxylic acid, an ester amino acid (“AA ester”) or a salt thereof, a polar aprotic solvent, a tertiary amine, ethyl-2-cyano-2-(hydroxyimino)acetate, and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) hydrochloride under suitable reaction conditions to form the compound of Formula (I); wherein the ester portion of the AA ester is an C 1 -C 10 unsubstituted alkyl or a C 1 -C 10 substituted alkyl. 2. The method of claim 1 , wherein 3,6-diamino-2,5-pyrazinedicarboxylic acid, the AA ester or salt thereof, the polar aprotic solvent, the tertiary amine, ethyl-2-cyano-2-(hydroxyimino)acetate, and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) hydrochloride are added in any sequential order, in any combination, or added all at once. 3. The method of claim 1 , wherein the method comprises: (a) contacting 3,6-diamino-2,5-pyrazinedicarboxylic acid with the AA ester or salt thereof in a polar aprotic solvent in a vessel to form a suspension; (b) contacting the suspension from step (a) with the tertiary amine; (c) contacting the suspension from step (b) with ethyl-2-cyano-2-(hydroxyimino)acetate; (d) contacting the suspension from step (c) with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) hydrochloride to form the compound of Formula (I). 4. The method of claim 1 , wherein the amino acid portion of the AA ester or salt thereof is a natural amino acid, an unnatural amino acid, or a synthetic amino acid. 5. The method of claim 1 , wherein the amino acid portion of the AA ester or salt thereof is a (R) configuration, a(S) configuration, or a racemic mixture. 6. The method of claim 1 , wherein the amino acid of the AA ester or salt thereof is (R)-serine. 7. The method of claim 1 , wherein the ester portion of the AA ester is a C 1 -C 8 unsubstituted alkyl or a C 1 -C 8 substituted alkyl. 8. The method of claim 1 , wherein the ester portion of the AA ester or salt thereof is methyl, ethyl, tert-butyl, or benzyl. 9. The method of claim 1 , wherein the ester of the AA ester or salt thereof is (R)-serine benzyl ester or (R)-serine benzyl ester HCl. 10. The method of claim 1 , wherein the tertiary amine is selected from the group consisting of trimethylamine, triethylamine, diisopropylethylamine, tripropylamine, tributylamine, 4-methylmorpholine, 4-ethylmorpholine, N-methylpyrrolidine, and N-methylpiperidine. 11. The method of claim 1 , wherein the AA ester and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at mole ratio from about 2.01:1.0 to about 2.20:1.0. 12. The method of claim 1 , wherein EDC HCl and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio from about 2.20:1.0 to about 2.50:1.0. 13. The method of claim 1 , wherein the ethyl-2-cyano-2-(hydroxyimino)acetate and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio from about 2.20:1.0 to about 2.50:1.0. 14. The method of claim 1 , wherein the tertiary amine and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio from about 2.10:1.0 to about 3.0:1.0. 15. The method of claim 1 , wherein the polar aprotic solvent is N,N-dimethylformamide, N—N-dimethylacetamide, or dimethylsulfoxide. 16. The method of claim 1 , wherein the polar aprotic solvent and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a volume (mL) to weight (gram) ratio from 10.0:1.0 to about 100.0:1.0. 17. The method of claim 1 , wherein the contacting of each step occurs at a temperature ranging from about-10° C. to about 30° C. 18. The method of claim 1 , wherein the contacting of each step of the method is conducted under helium, nitrogen, argon, or a combination thereof. 19. The method of claim 1 , wherein the compound of Formula (I) has a percent yield of at least 70%. 20. The method of claim 1 , wherein the compound of Formula (I) has a purity greater than about 95%. 21. The method of claim 1 , wherein the polar aprotic solvent is N,N-dimethylformamide; (R)-serine benzyl ester HCl and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio from about 2.01:1.0 to about 2.20:1.0; EDC HCl and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio ranging from about 2.20:1.0 to about 2.50:1.0; ethyl-2-cyano-2-(hydroxyimino)acetate and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio ranging from about 2.20:1.0 to about 2.50:1.0; diisopropylethylamine and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio ranging from about 2.10:1.0 to about 2.30:1.0; N, N-dimethylformamide and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a volume (mL) to weight (gram) ratio from 10.0:1.0 to about 100.0:1.0; and the contacting of each step occurs at a temperature from about −10° C. to about 30° C. 22. The method of claim 21 , wherein the compound of Formula (I) has a percent yield of at least 70%. 23. The method of claim 21 , wherein the compound of Formula (I) has a purity greater than about 95%. 24. The method of claim 1 , wherein the polar aprotic solvent is N,N-dimethylformamide; (R)-serine benzyl ester HCl and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio of about 2.10:1.0; EDC HCl and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio of about 2.30:1.0; ethyl-2-cyano-2-(hydroxyimino)acetate and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio of about 2.36:1.0; diisopropylethylamine and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a mole ratio of about 2.20:1.0; N,N-dimethylformamide and 3,6-diamino-2,5-pyrazinedicarboxylic acid are presented at a volume (mL) to weight (gram) ratio of is about 20.0:1.0; and contacting of each step of the method occurs at the temperature from about 0° C. to about 20° C. 25. The method of claim 24 , wherein the compound of Formula (I) has a percent yield of at least 80%. 26. The method of claim 24 , wherein the compound of Formula (I) has a purity greater than about 98%.

Assignees

Inventors

Classifications

  • C07D241/26Primary

    with nitrogen atoms directly attached to ring carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12319660B2 cover?
The present invention provides improved methods for preparing a compound comprising Formula (I).
Who is the assignee on this patent?
Medibeacon Inc
What technology area does this patent fall under?
Primary CPC classification C07D241/26. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).